Abstract
Understanding the tumor microenvironment and genomic landscape is crucial for better prediction of treatment outcomes and developing novel therapies in Hodgkin lymphoma (HL). Recent advancements in genomics have enabled researchers to gain deeper insights into the genomic characteristics of HL at both single‐cell resolution and the whole genome level. The use of noninvasive methods such as liquid biopsies and formalin‐fixed paraffin‐embedded‐based imaging techniques has expanded the possibilities of applying cutting‐edge analyses to routine clinically available samples. Collaborative efforts between adult and pediatric group are imperative to translate novel findings into routine patient care.